These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 31395855)
1. The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress. Chen W; Lian W; Yuan Y; Li M Cell Death Dis; 2019 Aug; 10(8):600. PubMed ID: 31395855 [TBL] [Abstract][Full Text] [Related]
2. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells. Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144 [TBL] [Abstract][Full Text] [Related]
3. Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer. Zou P; Chen M; Ji J; Chen W; Chen X; Ying S; Zhang J; Zhang Z; Liu Z; Yang S; Liang G Oncotarget; 2015 Nov; 6(34):36505-21. PubMed ID: 26431378 [TBL] [Abstract][Full Text] [Related]
4. Genipin Enhances the Therapeutic Effects of Oxaliplatin by Upregulating BIM in Colorectal Cancer. Kim BR; Jeong YA; Jo MJ; Park SH; Na YJ; Kim JL; Jeong S; Yun HK; Kang S; Lee DH; Oh SC Mol Cancer Ther; 2019 Apr; 18(4):751-761. PubMed ID: 30787174 [TBL] [Abstract][Full Text] [Related]
5. Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells. Rawat L; Hegde H; Hoti SL; Nayak V Biomed Pharmacother; 2020 Aug; 128():110243. PubMed ID: 32470748 [TBL] [Abstract][Full Text] [Related]
6. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice. Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338 [TBL] [Abstract][Full Text] [Related]
7. Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance. Zhang Y; Huang L; Shi H; Chen H; Tao J; Shen R; Wang T Cancer Sci; 2018 Jan; 109(1):94-102. PubMed ID: 29034540 [TBL] [Abstract][Full Text] [Related]
8. Decitabine exerted synergistic effects with oxaliplatin in colorectal cancer cells with intrinsic resistance to decitabine. Hosokawa M; Tanaka S; Ueda K; Iwakawa S; Ogawara KI Biochem Biophys Res Commun; 2019 Jan; 509(1):249-254. PubMed ID: 30581001 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related ( Combès E; Andrade AF; Tosi D; Michaud HA; Coquel F; Garambois V; Desigaud D; Jarlier M; Coquelle A; Pasero P; Bonnefoy N; Moreaux J; Martineau P; Del Rio M; Beijersbergen RL; Vezzio-Vie N; Gongora C Cancer Res; 2019 Jun; 79(11):2933-2946. PubMed ID: 30987998 [TBL] [Abstract][Full Text] [Related]
10. Shikonin potentiates therapeutic efficacy of oxaliplatin through reactive oxygen species-mediated intrinsic apoptosis and endoplasmic reticulum stress in oxaliplatin-resistant colorectal cancer cells. Zhang Z; Shen C; Zhou F; Zhang Y Drug Dev Res; 2023 May; 84(3):542-555. PubMed ID: 36779379 [TBL] [Abstract][Full Text] [Related]
11. Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer. Santoro V; Jia R; Thompson H; Nijhuis A; Jeffery R; Kiakos K; Silver AR; Hartley JA; Hochhauser D J Natl Cancer Inst; 2016 Jun; 108(6):djv394. PubMed ID: 26719345 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers. Wang Y; Lu JH; Wang F; Wang YN; He MM; Wu QN; Lu YX; Yu HE; Chen ZH; Zhao Q; Liu J; Chen YX; Wang DS; Sheng H; Liu ZX; Zeng ZL; Xu RH; Ju HQ Cancer Lett; 2020 Mar; 473():74-89. PubMed ID: 31904482 [TBL] [Abstract][Full Text] [Related]
13. Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer. Roh JL; Kim EH; Park JY; Kim JW; Kwon M; Lee BH Oncotarget; 2014 Oct; 5(19):9227-38. PubMed ID: 25193861 [TBL] [Abstract][Full Text] [Related]
14. Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G₀/G₁ to Apoptosis in HCT116 Human Colorectal Carcinoma Cells. Jang CH; Moon N; Oh J; Kim JS Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987009 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS. Cao P; Xia Y; He W; Zhang T; Hong L; Zheng P; Shen X; Liang G; Cui R; Zou P Int J Biol Sci; 2019; 15(8):1676-1684. PubMed ID: 31360110 [TBL] [Abstract][Full Text] [Related]
16. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway. Huang YF; Zhu DJ; Chen XW; Chen QK; Luo ZT; Liu CC; Wang GX; Zhang WJ; Liao NZ Oncotarget; 2017 Jun; 8(25):40264-40275. PubMed ID: 28402965 [TBL] [Abstract][Full Text] [Related]
17. Piperlongumine and immune cytokine TRAIL synergize to promote tumor death. Li J; Sharkey CC; King MR Sci Rep; 2015 May; 5():9987. PubMed ID: 25984950 [TBL] [Abstract][Full Text] [Related]
18. WBSCR22 confers oxaliplatin resistance in human colorectal cancer. Yan D; Tu L; Yuan H; Fang J; Cheng L; Zheng X; Wang X Sci Rep; 2017 Nov; 7(1):15443. PubMed ID: 29133897 [TBL] [Abstract][Full Text] [Related]
19. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer. Zou P; Xia Y; Ji J; Chen W; Zhang J; Chen X; Rajamanickam V; Chen G; Wang Z; Chen L; Wang Y; Yang S; Liang G Cancer Lett; 2016 May; 375(1):114-126. PubMed ID: 26963494 [TBL] [Abstract][Full Text] [Related]
20. Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction. Zheng A; Li H; Wang X; Feng Z; Xu J; Cao K; Zhou B; Wu J; Liu J Curr Cancer Drug Targets; 2014; 14(2):156-66. PubMed ID: 24274397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]